FcRn overexpression in human cancer drives albumin recycling and cell growth; a mechanistic basis for exploitation in targeted albumin-drug designs
Maja Thim Larsen, Ole Aalund Mandrup, Karen Kræmmer Schelde, Yonglun Luo, Karina D. Sørensen, Frederik Dagnæs‐Hansen, Jason Cameron, Magnus Stougaard, Torben Steiniche, Kenneth A. Howard
Topics & Concepts
AlbuminDrugHuman albuminPharmacologyTargeted drug deliveryChemistryCell growthCancer researchMedicineBiochemistryMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins ResearchChronic Lymphocytic Leukemia Research